

Erik Vollebregt
Life Sciences and IP Lawyer, and Founding Partner Axon LawyersErik is a lawyer specialised in EU legal issues relating to medical devices. He has wide experience in life sciences legislation and regulatory, at EU and Dutch level. Erik was trained as intellectual property and competition lawyer. He has gained experience in contentious matters, commercial contracts, and transactional work at the Directorate-General for Competition of the European Commission. He also worked for three large international law firms.
Erik worked and lived in Brussels for several years, and is fluent in Dutch, English, French, German, and Swedish. Erik is acknowledged by Chambers Europe for his work in the field of intellectual property and life sciences.
Erik’s software and engineering family background urged him to specialise in regulatory intellectual property and legal work in the medical technology industry. His clients range from the largest listed to the smallest startup companies.
Erik is a prolific writer and publishes in life sciences legal and regulatory journals on a wide variety of subjects. He is an editor of the Dutch life sciences law and regulatory journals Jurisprudentie Geneesmiddelenrecht and JGR Plus, as well as and author of a Dutch handbook on misleading and comparative advertising law Oneerlijke handelspraktijken, misleidende reclame en vergelijkende reclame. Additionally, he has a weblog on legal and regulatory aspects of medical technology, Medicaldeviceslegal. Erik is further authoring several medical technology chapters of RAPS’ EU Fundamentals of Regulatory Affairs. He often lectures at (inter)national conferences and is a guest lecturer on pharmaceutical law, medical technology law and advertising law at the universities of Groningen and Twente.
As additional external activity Erik is president of the NEN (Dutch Standardisation Institute) Platform on Software and Medical Devices.
His memberships include the Netherlands Biotech Industry Association (NIABA), the Dutch Association Pharmacy and Law (VFenR), the Dutch Association for Healthcare Law (Vereniging voor Gezondheidsrecht), the Dutch Association for Advertising Law (VvRr), and Regulatory Affairs Professional Society (RAPS)
Erik is also a cyclist, long distance runner, scuba diver, and Apple user.
Posted on 17.01.2013
The proposed scrutiny procedure: a measure proven to be ineffective in the world of pharma regulations


By Erik Vollebregt, Life Sciences and IP Lawyer, and Founding Partner Axon Lawyers
Posted on 12.04.2012
Standalone software: objects in the regulatory mirror may appear simpler than they are


By Erik Vollebregt, Life Sciences and IP Lawyer, and Founding Partner Axon Lawyers
Posted on 07.06.2011
eHealth applications and websites developed by clinicians: there are rules for that!


By Erik Vollebregt, Life Sciences and IP Lawyer, and Founding Partner Axon Lawyers